News
The salbutamol oral liquid market size has grown robustly in recent years, growing from $1.11 billion in 2024 to $1.17 billion in 2025, indicating a compound annual growth rate CAGR of 5.7%.
Single-Dose Intravenous Salbutamol Bolus for Managing Children With Acute Severe Asthma in the Emergency Department: Reanalysis of Data Gary J. Browne, FRACP, FACEM, Lawrence T. Lam, MApp, PsyMPH ...
Salbutamol was administered via a nebulizer at a dose of either 5 mg per 4 mL for children >2 yrs or 2.5 mg per 4 mL if ≤2 yrs. Doses were given every 20 mins together with continuous oxygen at ...
Rationale Salbutamol may affect lung function and exercise performance differently in individuals with and without asthma. Objectives To compare the effects of inhaled salbutamol on lung function, ...
The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...
Every week, the TDN posts a roundup of the relevant Horseracing Integrity and Safety Act (HISA)-related rulings from around ...
Researchers at Fraunhofer ITEM have shown for the first time that drug levels in the lung can be measured directly using particles in exhaled breath. For this breakthrough, Prof. Jens Hohlfeld and Dr.
Read about the role of nurses in a pilot project by Asthma + Lung UK that has seen health professionals appointed as ...
2d
ScienceAlert on MSNOzempic Alternative Ditches The Needle And One Major Side EffectA drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...
8d
Cyclingnews on MSNWhat does Diego Ulissi have in common with cycling superstars Sean Kelly, Erik Zabel, and Tom Boonen?However, the 2025 Giro dell'Appennino hosted a historic win as Diego Ulissi soloed home. The XDS-Astana rider scored a ...
Every week, the TDN posts a roundup of the relevant Horseracing Integrity and Safety Act (HISA) related rulings from around the country. The following rulings were reported on HISA's “rulings” portal ...
A new global systematic review and meta-analysis has found that overusing short-acting beta-agonist (SABA) inhalers-commonly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results